Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
EXACT Sciences Corporation
EXASCurrent price
45.00 USD
+1.46 USD (+3.35%)
Last closed
43.04 USD
Company
www.exactsciences.com
ISIN
US30063P1057
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NASDAQ
Capitalization
11 243 367 424 USD
Yield for 12 month
-22.02 %
1Y
3Y
5Y
10Y
15Y
EXAS
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. Address: 5505 Endeavor Lane, Madison, WI, United States, 53719
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
71.86 USDP/E ratio
–Dividend Yield
–Current Year
+2 499 766 000 USD
Last Year
+2 084 279 000 USD
Current Quarter
+708 655 000 USD
Last Quarter
+699 264 000 USD
Current Year
+1 845 518 000 USD
Last Year
+1 509 885 000 USD
Current Quarter
+512 555 000 USD
Last Quarter
+486 105 000 USD
Key Figures EXAS
1 year
3 years
5 years
10 years
EBITDA
-11 337 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-2.16 %
PEG Ratio
-1.07
Return On Equity TTM
-6.76 %
Wall Street Target Price
71.86 USD
Revenue TTM
2 692 327 936 USD
Book Value
17.35 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
12.80 %
Dividend Yield
–
Gross Profit TTM
1 509 885 000 USD
Earnings per share
-1.16 USD
Diluted Eps TTM
-1.16 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-7.95 %
Dividend Analytics EXAS
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History EXAS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Stock Valuation EXAS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
2 500.00
Enterprise Value Revenue
4.86
Price Sales TTM
4.18
Enterprise Value EBITDA
367.46
Price Book MRQ
3.53
Financials EXAS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators EXAS
For 52 weeks
40.62 USD
79.62 USD
50 Day MA
62.86 USD
Shares Short Prior Month
13 843 972
200 Day MA
58.24 USD
Short Ratio
3.25
Shares Short
11 828 001
Short Percent
6.45 %
BeatStart